CVS Health Corporation
CVS
NYSE67.64
CVS Health Corporation
NYSE:CVS
RECENT
PRICE
67.64
P/E
RATIO
21.80
(PEG:-0.46)
P/E RATIO
RELATIVE
TO S&P
0.90
DIV
YLD
2.54%
High:
Low:
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Legends
Stock price
0.60 Beta (1.0 Market)
0
0
0
0
0
0
0
0
0
% total return 05/23:
Stock
S&P
1y.
0
0
3y.
0
0
5y.
0
0
0
Percent shares traded:
0
0
0
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
Fiscal year
57.47
1.99
1.07
0.24
61.02
2.24
1.23
0.27
68.85
2.58
1.04
0.31
70.53
2.51
2.03
0.35
80.04
2.59
2.98
0.50
96.88
3.05
3.65
0.65
104.16
3.77
3.12
0.90
120.04
4.00
5.17
1.11
137.11
4.68
5.41
1.41
165.45
4.96
7.31
1.71
181.14
6.49
5.97
2.01
186.38
(0.57)
6.54
1.95
197.37
5.10
7.99
2.00
205.28
5.48
10.26
2.00
223.16
6.03
12.03
2.01
245.78
3.16
10.25
2.22
253.53
3.09
13.32
2.27
Revenue per share
Earnings per share
Free Cash Flow per sh
Dividends per share
1.36
23.58
1.52
24.12
1.78
24.94
1.47
27.58
1.40
28.44
1.60
29.66
1.63
31.17
1.84
32.69
2.12
33.27
2.07
34.32
1.88
36.95
1.95
55.77
1.89
49.09
1.86
53.01
1.93
57.59
2.08
54.13
2.04
55.21
CAPEX per share
Book Value per share
1,328
1,434
1,434
1,367
1,338
1,271
1,217
1,161
1,118
1,073
1,020
1,044
1,301
1,309
1,309
1,312
1,305
Comm.Shares outs.(m)
18.4
1.1
0.7%
16.2
0.8
0.7%
12.2
0.2
1.0%
12.9
0.6
1.1%
13.9
0.9
1.4%
14.9
1.0
1.4%
15.5
0.9
1.5%
19.5
1.1
1.4%
21.4
1.1
1.4%
18.7
0.8
1.9%
12.0
0.5
2.6%
(124.7)
(5.0)
2.8%
12.0
0.5
3.3%
11.7
0.3
3.1%
13.6
0.5
2.4%
31.4
1.5
2.2%
21.8
0.9
2.5%
Avg. annual P/E ratio
P/E relative to S&P500
Avg. annual div. yield
Capital Structure (31/3/23 | Q1)
Total liabilities
$167,750 m.
Total assets
$239,330 m.
Long-term debt
$73,021 m.
Cash and equiv.
$14,618 m.
Goodwill $84,057 m.
Retained earnings $57,753 m.
Common stock 1,283 m. shares
Market Capitalisation
$86,717 m. (as of 28/5/23)
123,133
5.9%
126,761
6.3%
139,367
6.3%
153,290
6.2%
177,526
5.8%
184,765
5.2%
194,579
2.1%
256,776
4.7%
268,706
5.2%
292,111
4.5%
322,467
2.4%
330,919
4.4%
Revenue (m)
Operating margin
1,753
3,877
1,870
4,592
1,931
4,644
2,092
5,237
2,475
5,317
2,479
6,622
2,718
(594)
4,371
6,634
4,441
7,179
- -
7,898
- -
4,149
3,213
3,986
Depreciation (m)
Net profit (m)
38.6%
3.1%
38.9%
3.6%
39.5%
3.3%
39.3%
3.4%
38.4%
3.0%
19.8%
3.6%
142.4%
(0.3)%
26.3%
2.6%
26.3%
2.7%
24.2%
2.7%
26.0%
1.3%
25.4%
1.2%
Income tax rate
Net profit margin
6,062
9,133
37,704
9,900
12,841
37,938
6,956
11,695
37,958
7,209
26,267
37,196
4,792
25,615
36,830
581
22,181
37,691
1,234
71,444
58,225
(3,001)
64,699
63,864
(5,648)
77,964
69,389
(7,799)
88,325
75,381
(4,054)
67,276
71,015
(6,348)
73,021
71,382
Working capital (m)
Long-term debt (m)
Equity (m)
8.1%
10.4%
10.3%
8.8%
11.2%
12.1%
9.1%
11.2%
12.2%
8.2%
10.1%
14.1%
8.8%
10.3%
14.4%
11.6%
9.8%
17.6%
(1.1)%
2.1%
(1.0)%
5.3%
5.4%
10.4%
5.5%
5.5%
10.3%
5.9%
5.5%
10.5%
3.7%
3.5%
5.8%
6.6%
6.1%
5.6%
ROIC
Return on capital
Return on equity
Working Capital
2020
2021
2022
Cash assets
10,854
12,408
15,945
Receivables
21,742
24,431
27,276
Inventory
18,496
17,760
19,090
Other
5,277
5,292
3,593
Current assets
56,369
60,008
65,682
Acc. Payable
11,138
12,544
14,838
Debt due
7,078
4,938
3,456
Other
43,801
50,325
51,442
Current liab.
62,017
67,807
69,736
78.6%
111.2%
76.1%
133.5%
72.3%
88.1%
69.9%
108.8%
65.4%
80.3%
69.1%
105.3%
443.1%
- -
60.8%
25.1%
63.4%
19.5%
66.8%
16.7%
(Infinity)%
47.6%
(60.0)%
33.5%
Plowback ratio
Div.&Repurch. to FCF
CVS Health Corporation (US) started trading on October 3, 1952 (cik: 0000064803), operates in the Healthcare sector (Healthcare Plans industry), has 219,000 full-time employees, and is led by Ms. Karen Sue Lynch. CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Annual rates
(avg rate of change)
Past
5 y.
Past
10 y.
Revenues
13.93%
11.21%
Cash flow
21.02%
18.03%
Earnings
-311.52%
-146.12%
Dividends
9.83%
11.85%
Book value
5.29%
8.34%
Insider trading
Type
Shares
Date
Millon Jean Pierre
Award
1,437
05/18/23
Finucane Anne A.
Award
1,437
05/18/23
Deparle Nancy Ann
Award
1,437
05/18/23
Balser Jeffrey R.
Award
1,329
05/18/23
Aguirre Fernando
Award
1,329
05/18/23
Fiscal Year Ends
Quarterly Revenue (m)
Full fiscal year
I
II
III
IV
2021
69,097
72,616
73,794
76,604
292,111
2022
76,826
80,636
81,159
83,846
322,467
2023
85,278
- -
- -
- -
- -
Fiscal Year Ends
Earnings per share
Full fiscal year
I
II
III
IV
2021
1.70
2.13
1.22
0.99
6.04
2022
1.76
2.25
(2.60)
1.75
3.17
2023
1.67
- -
- -
- -
- -
Fiscal Year Ends
Quarterly dividends paid
Full fiscal year
I
II
III
IV
2021
0.50
0.50
0.50
0.50
2.01
2022
0.55
0.56
0.55
0.55
2.22
2023
0.61
- -
- -
- -
- -
05/03/2023
CVS Posts Higher Revenue as Acquisitions Close
The Wall Street Journal - Read more...
03/29/2023
Those Dreaded Medical Forms Are About to Be Scaled Back
The Wall Street Journal - Read more...
03/01/2023
Congress Investigates How Pharma Middlemen Affect Drug Prices
The Wall Street Journal - Read more...
02/19/2023
Walgreens CEO Bets on Doctors Over Drugstores in Search for Growth
The Wall Street Journal - Read more...
02/13/2023
Opioid Settlement Money Is Coming. Two Ohio Counties Differ on How to Spend It.
The Wall Street Journal - Read more...
02/08/2023
CVS Makes $10 Billion Bet on Seniors
The Wall Street Journal - Read more...
02/08/2023
CVS Reaches $10.6 Billion Deal to Buy Oak Street Health
The Wall Street Journal - Read more...
02/07/2023
CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street Health
The Wall Street Journal - Read more...
01/27/2023
CVS, Walmart to Cut Pharmacy Hours
The Wall Street Journal - Read more...
12/04/2022
CVS Tries Out Remote System to Help Fill Prescriptions
The Wall Street Journal - Read more...
11/02/2022
CVS, Walgreens to Pay More Than $10 Billion to Settle Opioid Lawsuits
The Wall Street Journal - Read more...
09/22/2022
Humana, CVS Circle Cano Health as Potential Buyers
The Wall Street Journal - Read more...
09/05/2022
CVS Announces Deal to Acquire Home-Healthcare Company Signify
The Wall Street Journal - Read more...
08/07/2022
CVS Plans to Bid for Signify Health
The Wall Street Journal - Read more...
08/03/2022
CVS Lifts Outlook After Second-Quarter Sales Rose 11%
The Wall Street Journal - Read more...
07/28/2022
New York Attorney General Sues CVS for Violating Antitrust Laws
The Wall Street Journal - Read more...
07/08/2022
CVS Introduces New C-Level Role to Guide Tech Strategy
The Wall Street Journal - Read more...
07/01/2022
Delta Air Lines, Nike, Snap: Stocks That Defined the Week
The Wall Street Journal - Read more...
06/14/2022
Mental-Health Startup Cerebral Investigated by FTC
The Wall Street Journal - Read more...
06/07/2022
FTC to Probe CVS Caremark and Other Pharmacy-Benefit Managers
The Wall Street Journal - Read more...
05/26/2022
Walmart, CVS to Stop Filling Controlled-Substance Prescriptions for Cerebral, Done
The Wall Street Journal - Read more...
05/04/2022
CVS Sales Up 11%, Lifted by Vaccine, Test-Kit Demand
The Wall Street Journal - Read more...
04/27/2022
Walmart, CVS Block or Delay Telehealth Adderall Prescriptions
The Wall Street Journal - Read more...
03/11/2022
CVS Ousts Executives After Inquiry, Vows to Overhaul How It Handles Sexual-Harassment Complaints
The Wall Street Journal - Read more...
02/09/2022
CVS Expects Sales Boost From Covid-19 to Wane
The Wall Street Journal - Read more...
02/09/2022
Enphase Energy, Chipotle, Peloton, Uber: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
01/14/2022
Walgreens, CVS Shut Some Pharmacies on Weekends as Omicron Strains Staffing
The Wall Street Journal - Read more...
12/09/2021
In the Market: GameStop, Novavax, Rent the Runway, DWAC
The Wall Street Journal - Read more...
11/24/2021
Walgreens, Walmart, CVS Contributed to Opioid Epidemic, Ohio Jury Finds
The Wall Street Journal - Read more...
11/18/2021
CVS to Close 900 Stores Over Three Years
The Wall Street Journal - Read more...
11/03/2021
CVS Looks to Add Doctors to Its Payroll
The Wall Street Journal - Read more...
11/03/2021
Bed Bath & Beyond Surges: What to Watch in the Stock Market Today
The Wall Street Journal - Read more...
09/24/2021
Pharmacies Prepare for Broader Covid-19 Booster Distribution
The Wall Street Journal - Read more...
09/20/2021
CVS Makes Hiring Push Amid Worker Shortage, Demand for Vaccines
The Wall Street Journal - Read more...
08/29/2021
CVS Wants to Be Your Therapist, Too
The Wall Street Journal - Read more...
08/12/2021
Clover Health, Palantir, Coupang: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
08/04/2021
CVS Stock Will Be Fine Once Vaccines Wear Off
The Wall Street Journal - Read more...
08/04/2021
Robinhood, Victoria’s Secret, Activision, GM: What to Watch When the Stock Market Opens Today
The Wall Street Journal - Read more...
08/04/2021
CVS Logs Higher Revenue Boosted by Covid-19 Shots
The Wall Street Journal - Read more...